1. Home
  2. HOTH vs XTKG Comparison

HOTH vs XTKG Comparison

Compare HOTH & XTKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • XTKG
  • Stock Information
  • Founded
  • HOTH 2017
  • XTKG 1997
  • Country
  • HOTH United States
  • XTKG Singapore
  • Employees
  • HOTH 3
  • XTKG N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • XTKG
  • Sector
  • HOTH Health Care
  • XTKG
  • Exchange
  • HOTH Nasdaq
  • XTKG NYSE
  • Market Cap
  • HOTH 16.0M
  • XTKG 16.3M
  • IPO Year
  • HOTH 2019
  • XTKG 2019
  • Fundamental
  • Price
  • HOTH $1.44
  • XTKG $1.86
  • Analyst Decision
  • HOTH Strong Buy
  • XTKG
  • Analyst Count
  • HOTH 3
  • XTKG 0
  • Target Price
  • HOTH $4.00
  • XTKG N/A
  • AVG Volume (30 Days)
  • HOTH 733.2K
  • XTKG 107.4K
  • Earning Date
  • HOTH 05-12-2025
  • XTKG 07-22-2025
  • Dividend Yield
  • HOTH N/A
  • XTKG N/A
  • EPS Growth
  • HOTH N/A
  • XTKG N/A
  • EPS
  • HOTH N/A
  • XTKG N/A
  • Revenue
  • HOTH N/A
  • XTKG $11,611,442.00
  • Revenue This Year
  • HOTH N/A
  • XTKG N/A
  • Revenue Next Year
  • HOTH N/A
  • XTKG N/A
  • P/E Ratio
  • HOTH N/A
  • XTKG N/A
  • Revenue Growth
  • HOTH N/A
  • XTKG N/A
  • 52 Week Low
  • HOTH $0.58
  • XTKG $0.53
  • 52 Week High
  • HOTH $3.80
  • XTKG $11.60
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 62.68
  • XTKG 57.60
  • Support Level
  • HOTH $1.17
  • XTKG $1.68
  • Resistance Level
  • HOTH $1.34
  • XTKG $1.83
  • Average True Range (ATR)
  • HOTH 0.10
  • XTKG 0.25
  • MACD
  • HOTH 0.02
  • XTKG 0.01
  • Stochastic Oscillator
  • HOTH 77.27
  • XTKG 60.61

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About XTKG X3 HOLDINGS CO LTD

X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries. It generates revenue from service lines: Application development services; Consulting and technical support services; Subscription services; Trading; and Others, of which maximum revenue is derived from Application development services. Geographically, all of the company's revenue is derived from PRC.

Share on Social Networks: